Literature DB >> 6855803

Spinal muscular atrophy: the natural course of disease.

B S Russman, R Melchreit, J C Drennan.   

Abstract

The infantile form of spinal muscular atrophy (Werdnig-Hoffmann disease) is thought to be progressive and usually fatal by age three. The intermediate and juvenile forms (Kugelberg-Welander disease) have been reported to be static in many cases. A review of 48 patients, 50% of whom had been followed for more than 10 years, were placed into four groups according to the maximum motor function attained. Progression of muscle weakness was assessed using functional criteria, including inability to walk, inability to use a manual wheelchair and inability to raise the hands above the head. The results of this analysis suggest that all patients with spinal muscular atrophy have a progressive disease and that the course of the deterioration is predictable in each of the four groups. This information allows one to offer realistic counseling and a rational rehabilitation program.

Entities:  

Mesh:

Year:  1983        PMID: 6855803     DOI: 10.1002/mus.880060302

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice.

Authors:  Farah Chali; Céline Desseille; Léo Houdebine; Evelyne Benoit; Thaïs Rouquet; Bruno Bariohay; Philippe Lopes; Julien Branchu; Bruno Della Gaspera; Claude Pariset; Christophe Chanoine; Frédéric Charbonnier; Olivier Biondi
Journal:  J Physiol       Date:  2016-02-27       Impact factor: 5.182

2.  Motor unit number estimation in infants and children with spinal muscular atrophy.

Authors:  Mark B Bromberg; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2002-03       Impact factor: 3.217

Review 3.  Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence.

Authors:  Helgi Thor Hjartarson; Kristofer Nathorst-Böös; Thomas Sejersen
Journal:  Drug Des Devel Ther       Date:  2022-06-16       Impact factor: 4.319

4.  Prospective study of gross motor development in children with SMA type II.

Authors:  R Bono; M Inverno; G Botteon; E Iotti; M Estienne; A Berardinelli; G Lanzi; E Fedrizzi
Journal:  Ital J Neurol Sci       Date:  1995-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.